Focus: Butterfly Biosciences is a publicly traded medical device and technology company focused on minimally invasive, lower-cost solutions for gynecologic, fertility, and urology care. The company operates at a small scale with 9 active job openings and a lean organizational footprint.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
3 added, 2 removed. Backfill posture.
Butterfly Biosciences represents a high-risk, early-stage opportunity in an attractive therapeutic area, but severe data gaps on financials, pipeline maturity, and hiring velocity make this a speculative career move best suited for founders and risk-tolerant technologists.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Butterfly Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Butterfly Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles